Palatin Technologies
PTN
#9923
Rank
ยฃ29.39 M
Marketcap
ยฃ17.26
Share price
4.59%
Change (1 day)
2,268.70%
Change (1 year)

Revenue for Palatin Technologies (PTN)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of ยฃ0.27 Million a decrease over the revenue in the year 2023 that were of ยฃ5.57 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Palatin Technologies from 1998 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A-100%
2024 ยฃ0.27 M-94.99%
2023 ยฃ5.57 M133.79%
2022 ยฃ2.38 M331.44%
2021 ยฃ0.55 M-266.37%
2020 -ยฃ0.34 Million-100.72%
2019 ยฃ46.04 M97.37%
2018 ยฃ23.33 M-61.68%
2017 ยฃ60.87 M
2016 N/A
2015 N/A-100%
2014 ยฃ8.31 M
2013 N/A-100%
2012 ยฃ0.02 M-82.94%
2011 ยฃ0.16 M-94.34%
2010 ยฃ2.91 M-76.84%
2009 ยฃ12.56 M393.97%
2008 ยฃ2.54 M-67.29%
2007 ยฃ7.77 M-18.53%
2006 ยฃ9.54 M-10.46%
2005 ยฃ10.66 M115.5%
2004 ยฃ4.94 M248.77%
2003 ยฃ1.41 M115.55%
2002 ยฃ0.65 M142.62%
2001 ยฃ0.27 M-89.56%
2000 ยฃ2.59 M46.77%
1999 ยฃ1.77 M267.9%
1998 ยฃ0.48 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
MediciNova
MNOV
ยฃ0.1 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ2.01 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.62 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ0.14 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ0.29 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ43.63 BN/A๐Ÿ‡ฌ๐Ÿ‡ง UK